Metoclopramide tablets recalled for presence of foreign tablets
Teva Pharmaceuticals is recalling Metoclopramide 10 mg tablets due to the presence of foreign tablets or capsules within affected cartons. Patients should contact their pharmacy if they received medication from the affected lot.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for contamination in a prescription medication. No illnesses or injuries are reported. The presence of unidentified foreign tablets in a medication batch represents a risk-of-harm product, though the actual hazard remains theoretical without reported incidents.
Plain-English summary
Teva Pharmaceuticals USA, Inc. is recalling Metoclopramide Tablets, USP 10 mg supplied in 100-count bottles due to the presence of foreign tablets or capsules within cartons of the recalled medication.
The affected product was distributed nationwide. The specific lot involved is Lot# 5420094 with an expiration date of 09/30/2027. Approximately 36,612 cartons are included in this recall.
Patients who have received Metoclopramide from the affected lot should contact their pharmacy or healthcare provider immediately. They should not use the medication and should return it to their pharmacy. Healthcare providers and pharmacies should check their inventory against the lot number to identify and quarantine affected stock.
The recalled product
- Product
- METOCLOPRAMIDE (METOCLOPRAMIDE)
- Brand
- METOCLOPRAMIDE
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Category
- Drug — Prescription Medication
- Hazard
- contamination
- foreign-object
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 5420094
- Exp 09/30/2027
UPCs (2)
- 0300932203013
- 0300932204010
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METOCLOPRAMIDE
- SevereMetoclopramide Injection Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-08-25
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27